1. Brunner N, Bronzert D, Vindelov LL, Rygaard K, Spang-Thomsen M, Lippman ME (1989) Effect on growth and cell cycle kinetics of estradiol and tamoxifen on MCF-7 human breast cancer cells grown in vitro and in nude mice. Cancer Res 49: 1515–1520.
2. Bates SE, Davidson NE, Valverius EM, Dickson RB, Freter CE, Tam JP, Kulow JE, Lippman ME, Salomon S (1988) Expression of transforming growth factor alpha and its messenger ribonucleic acid in human breast cancer, its regulation by estrogen and its possible functional significance. Mol Endocrinol 2: 543–545.
3. Knabbe C, Lippman ME, Wakefield LM, Flanders KC, Kasid A, Derynck R, Dickson RB (1987) Evidence that transforming growth factor-β is a hormonally regulated negative growth factor in human breast cancer cells. Cell 48: 417–428.
4. Roberts AB, Sporn MB (1992) Mechanistic interrelationships between two superfamilies: The steroid/retinod receptors and transforming growth factor-β. In Cancer Surveys, Vol 14. MG Parker (ed). Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, pp 205–220.
5. Stewart AJ, Johnson MD, May FEB, Westley BR (1990) Role of insulin-like growth factors and the Type I insulin-like growth factor receptor in the estrogen-stimulated proliferation of human breast cancer cells. J Biol Chem 265: 21172–21178.